Research output per year
Research output per year
Personal profile
Education/Academic qualification
3.2 Clinical medicine, Expert, Latvian Council of Science
26 May 2020 → 25 May 2023
3.2 Clinical medicine, Expert, Latvian Council of Science
18 Mar 2017 → 16 Mar 2020
Field of Science
- 3.2 Clinical medicine
Fingerprint
Dive into the research topics where Inga Stuķēna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
PAI-1 level differences in malignant plural effusion, parapneumonic pleuritis, and cardiac hydrothorax
Zentina, D., Stukena, I., Krams, A. & Lejnieks, A., Sep 2019, In: Medicina (Lithuania). 55, 9, 567.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus) -
Cognitive function in a randomized trial of evolocumab
EBBINGHAUS Investigators, Giugliano, R. P. & Stuķēna, I., 17 Aug 2017, In: New England Journal of Medicine. 377, 7, p. 633-643 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile153 Citations (Scopus) -
Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy
APEX Investigators & Stukena, I., 1 Jul 2017, In: Journal of the American Heart Association. 6, 7, e006015.Research output: Contribution to journal › Article › peer-review
Open AccessFile28 Citations (Scopus)27 Downloads (Pure) -
Evolocumab and clinical outcomes in patients with cardiovascular disease
FOURIER Steering Committee and Investigators & Stukena, I., 4 May 2017, In: New England Journal of Medicine. 376, 18, p. 1713-1722 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2704 Citations (Scopus) -
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)
APEX Investigators & Stukena, I., 14 Feb 2017, In: Circulation. 135, 7, p. 648-655Research output: Contribution to journal › Article › peer-review
Open AccessFile51 Citations (Scopus)74 Downloads (Pure)
Activities
- 2 Membership of NGOs
-
Latvian Medical Association (External organisation)
Inga Stuķēna (Member)
2020 → …Activity: Membership types › Membership of NGOs
-
Latvian Internists' Society (External organisation)
Inga Stuķēna (Member)
2020 → …Activity: Membership types › Membership of NGOs